JPH0249714A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH0249714A JPH0249714A JP19978788A JP19978788A JPH0249714A JP H0249714 A JPH0249714 A JP H0249714A JP 19978788 A JP19978788 A JP 19978788A JP 19978788 A JP19978788 A JP 19978788A JP H0249714 A JPH0249714 A JP H0249714A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- surfactants
- acid
- dandruff
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 25
- 208000001840 Dandruff Diseases 0.000 claims abstract description 20
- 239000004094 surface-active agent Substances 0.000 claims abstract description 17
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 8
- 230000002087 whitening effect Effects 0.000 claims description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 239000004519 grease Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 27
- -1 ether carboxylic acids Chemical class 0.000 description 26
- 230000000694 effects Effects 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 235000010323 ascorbic acid Nutrition 0.000 description 6
- 239000011668 ascorbic acid Substances 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000005342 ion exchange Methods 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000000440 bentonite Substances 0.000 description 4
- 229910000278 bentonite Inorganic materials 0.000 description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 239000002734 clay mineral Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 3
- 244000061508 Eriobotrya japonica Species 0.000 description 3
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 3
- 241000234435 Lilium Species 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000010495 camellia oil Substances 0.000 description 3
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229960004705 kojic acid Drugs 0.000 description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 125000001273 sulfonato group Chemical class [O-]S(*)(=O)=O 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- 235000014692 zinc oxide Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 229940105847 calamine Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 229910052864 hemimorphite Inorganic materials 0.000 description 2
- 235000020721 horse chestnut extract Nutrition 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000002270 phosphoric acid ester group Chemical group 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229940081510 piroctone olamine Drugs 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- 229960001325 triclocarban Drugs 0.000 description 2
- 229940045136 urea Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 229930007886 (R)-camphor Natural products 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- QCTZUSWOKFCWNB-QXMHVHEDSA-N (z)-n,n-dimethyloctadec-9-en-1-amine oxide Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)[O-] QCTZUSWOKFCWNB-QXMHVHEDSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 244000050983 Luffa operculata Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000609816 Pantholops hodgsonii Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical class NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- ZIALXKMBHWELGF-UHFFFAOYSA-N [Na].[Cu] Chemical compound [Na].[Cu] ZIALXKMBHWELGF-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 210000001643 allantois Anatomy 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229920003045 dextran sodium sulfate Polymers 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- SPCNPOWOBZQWJK-UHFFFAOYSA-N dimethoxy-(2-propan-2-ylsulfanylethylsulfanyl)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)SCCSC(C)C SPCNPOWOBZQWJK-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- BVMJGZKBXAVKJN-UQKRIMTDSA-M sodium;(4s)-4-amino-5-dodecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O BVMJGZKBXAVKJN-UQKRIMTDSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野1
本発明は、薬剤のもつ効果を十分発揮させた化粧1′1
に関する。川に詳しりi、:文、アニオン性界面活性剤
の一種又は二種以」―と、アニオン性界面活性剤以外で
分子内に窒素原子を有する界面活性剤の一種又は二種以
上と、美白剤、フケ防止剤及び抗脂漏剤からなる詳から
選ばれる一種又は二種以上とを含有することを特徴とす
る化粧11に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field 1] The present invention provides cosmetics 1'1 that fully exhibits the effects of drugs.
Regarding. Kawani Familiar i: Text, one or more types of anionic surfactants, one or more types of surfactants other than anionic surfactants that have a nitrogen atom in the molecule, and skin whitening. The present invention relates to cosmetics 11 characterized in that it contains one or more selected from the group consisting of anti-dandruff agents, anti-dandruff agents, and anti-seborrheic agents.
[従来の技術1
皮膚の表面は皮rR角質層と呼ばれ、本来、体外からの
異物の侵入を防御するバリヤーとしての生理的機能を有
するものであるため、ただ単に従来化粧料に常用されて
きた基剤中に薬効成分を配合しただけでは、充分な薬剤
の効果が得られない。[Prior art 1] The surface of the skin is called the stratum corneum, and it originally has a physiological function as a barrier to prevent foreign substances from entering the body. Merely blending the medicinal ingredients into a base will not produce sufficient drug effects.
[発明が解決しようとする課題1
本発明者等は上記問題点に鑑み、薬効成分の持つ効果を
充分発揮される化粧料を開発すべく鋭意団究した結果、
本発明を完成するに至った。[Problem to be Solved by the Invention 1] In view of the above-mentioned problems, the present inventors have conducted intensive research to develop cosmetics that fully exhibit the effects of medicinal ingredients.
The present invention has now been completed.
[課題を解決するための手段1
すなわち本発明は、アニオン性界面活性剤の一種又は二
種以上と、アニオン性界面活性剤以外で分子内に窒素原
子を有する界面活性剤の一種又は二種以上、と、美白剤
、フケ防止剤及び抗脂漏剤からなる群から選ばれる一種
又は二種以−ヒとを含有することを特徴とする化粧料で
ある。[Means for Solving the Problems 1] That is, the present invention uses one or more anionic surfactants and one or more surfactants other than the anionic surfactants that have a nitrogen atom in the molecule. , and one or more selected from the group consisting of a whitening agent, an anti-dandruff agent, and an anti-seborrheic agent.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明に用いられるアニオン性界面活性剤としては、カ
ルボン酸基、スルポン酸基、硫酸エステル基、リン酸エ
ステル基を分子内に一種又は二種以上有するものであれ
ば何でも良く、カルボン酸基を有するものとしては脂肪
酸セッケン、エーテルカルボン酸およびその塩、アミノ
酸と脂肪酸の縮合物等のカルボン酸塩等を、又、スルホ
ン酸塩を有するものとしては、アルキルスルホン酸塩、
スルホコハク酸、エステルスルホン酸塩、アルキルアリ
ル及びアルキルナフタレンスルホン酸塩、N−アシルス
ルホン酸塩、ホルマリン縮合系スルホン酸塩等を、硫酸
エステル基を有する乙のとしては、硫酸化油、エステル
硫酸塩、アルキル硫酸塩、エーテル硫酸塩、アルキルア
リルエーテル硫酸塩、アミド硫酸塩等を、リン酸エステ
ル基を有するものとしては、アルキルリン酸塩、アミド
リン酸塩、エーテルリン酸塩、アルキルアリルエーテル
リン酸塩等を挙げることができる。これらの中から一種
または二種以上が任意に選択される。The anionic surfactant used in the present invention may be any one having one or more types of carboxylic acid group, sulfonic acid group, sulfuric acid ester group, or phosphoric acid ester group in the molecule. Those containing fatty acid soaps, ether carboxylic acids and their salts, carboxylic acid salts such as condensates of amino acids and fatty acids, etc., and those containing sulfonates include alkyl sulfonates,
Examples of sulfosuccinic acid, ester sulfonates, alkylaryl and alkylnaphthalene sulfonates, N-acylsulfonates, formalin condensation sulfonates, etc. having sulfate ester groups include sulfated oils and ester sulfates. , alkyl sulfates, ether sulfates, alkyl allyl ether sulfates, amide sulfates, etc., and those having a phosphoric acid ester group include alkyl phosphates, amide phosphates, ether phosphates, alkyl allyl ether phosphates, etc. Examples include salt. One or more types are arbitrarily selected from these.
本発明に用いられるアニオン性界面活性剤以外で分子内
に窒素原子を有する界面活性剤としては、窒素原子を分
子内に有する両性界面活性剤、半極性界面活性剤、非イ
オン性界面活性剤、カチオン性界面活性剤等を挙げるこ
とができる。両性界面活性剤としては、カルボキシベタ
イン、スルホベタイン、アミノカルボン酸塩、イミダシ
リン誘導体等を、半極性界面活性剤としては、アミンオ
キシド等を、非イオン性界面活性剤としては、脂肪酸ア
ルカノールアミド、ポリオキシエチレン脂肪酸アミド、
アルカノールアミンのエステル、ポリオキシエチレンア
ルキルアミン等を、カチオン性界面活性剤としては、脂
肪酸アミン塩、アルキル四級アンモニウム塩、芳香族四
級アンモニウム塩、ピリジウム塩、イミダゾリウム塩等
を挙げることができる。これらの中から一種又は二種以
上が任意に選択され用いられる。Examples of surfactants having a nitrogen atom in the molecule other than the anionic surfactant used in the present invention include amphoteric surfactants having a nitrogen atom in the molecule, semipolar surfactants, nonionic surfactants, Examples include cationic surfactants. Amphoteric surfactants include carboxybetaine, sulfobetaine, aminocarboxylic acid salts, imidacillin derivatives, etc., semipolar surfactants include amine oxides, and nonionic surfactants include fatty acid alkanolamides, polyamides, etc. oxyethylene fatty acid amide,
Examples of cationic surfactants include alkanolamine esters, polyoxyethylene alkylamine, etc., and fatty acid amine salts, alkyl quaternary ammonium salts, aromatic quaternary ammonium salts, pyridium salts, imidazolium salts, etc. . One or more of these may be arbitrarily selected and used.
本発明で用いられるアニオン性界面活性剤と、アニオン
性界面活性剤以外で分子内に窒素原子を何する界面活性
剤との配合割合は、分子比で20:1〜1:20が好ま
しく、ざらに好ましくは10:1〜1:10である。The blending ratio of the anionic surfactant used in the present invention and a surfactant other than the anionic surfactant that has a nitrogen atom in its molecule is preferably 20:1 to 1:20 in terms of molecular ratio. The ratio is preferably 10:1 to 1:10.
本発明に用いられる美白剤としては、アスコルビン酸、
シバルミチン酸アスコルビル、アスコルビン酸2−硫酸
、ユキノシタ抽出物、プラセンタ抽出物、コウジ酸等が
挙げられる。As the whitening agent used in the present invention, ascorbic acid,
Examples include ascorbyl civalmitate, ascorbic acid 2-sulfuric acid, saxifrage extract, placenta extract, kojic acid, and the like.
本発明に用いられるフケ防止剤としては、ジンクピリチ
オン、トリクロロカルバニリド、ピロクトンオラミン等
が挙げられる。Anti-dandruff agents used in the present invention include zinc pyrithione, trichlorocarbanilide, piroctone olamine, and the like.
本発明に用いられる抗脂漏剤としては、イオウ、シャク
ヤク、ボタンピ、塩酸ピリドキシン、トリパルミチン酸
ピリドキシン、オトギリソウ等が挙げられる。Examples of the antiseborrheic agent used in the present invention include sulfur, peony, botanical, pyridoxine hydrochloride, pyridoxine tripalmitate, Hypericum perforatum, and the like.
本発明で用いられる美白剤、フケ防止剤及び抗脂漏剤は
、本発明の界面活性剤と混合して用いて皮膚に塗布する
ことにより、薬剤の持つ効果が充分発揮される。局所作
用を目的とする薬効成分ならびに全身作用を目的とする
薬効成分とも同様に優れた効果を発揮する。When the whitening agent, anti-dandruff agent, and anti-seborrheic agent used in the present invention are mixed with the surfactant of the present invention and applied to the skin, the effects of the agents are fully exhibited. Both medicinal ingredients intended for local action and medicinal ingredients intended for systemic action exhibit excellent effects.
本発明で用いられる美白剤、フケ防止剤及び抗脂漏剤の
配合量は、所望の薬効を奏するに充分な量であればよく
、それは薬効成分の種類、使用者の肌質、症状等によっ
て異なるものであり、−概にはいえないが、概ね薬効成
分1重量%に対して、本界面活性剤0.001〜50重
量%である。The amount of the whitening agent, anti-dandruff agent, and anti-seborrheic agent used in the present invention may be sufficient as long as it has the desired medicinal effect, and it depends on the type of medicinal ingredient, the skin type and symptoms of the user, etc. Although it cannot be said generally, the amount of the present surfactant is approximately 0.001 to 50% by weight per 1% by weight of the medicinal ingredient.
上記の界面活性剤は、薬効成分を適宜混合してそのまま
用いてもよいが、使用感触や適用のしゃすぎ等を勘案し
て、−船釣には構成成分を適当な化粧料中、例えばクリ
ーム、ゲル、ローション、乳液等の基剤中に混合して用
いられる。The above-mentioned surfactants may be used as they are after appropriately mixing the medicinal ingredients, but taking into consideration the feel of use and the ease of application, for boat fishing, the constituent ingredients may be added to a suitable cosmetic, such as a cream. It is used by mixing it into the base of gel, lotion, milky lotion, etc.
その場合の各々の構成成分の配合量は、同じ(薬効成分
の種類等によって異なるが、概ね以下の範囲が好ましい
配合量範囲である。すなわち、ア二」ン性界面活性剤及
びアニオン性界面活性剤以外で分子内に窒素原子を有す
る界面活性剤の合計配合量は化粧料中0.001〜10
重量%が好ましく、J:り好ましくは0.01〜5重量
%であり、薬効成分は0.001〜10重量%が好まし
く、より好ましくは0゜01〜5重量%である。また、
アニオン性界面活性剤と、アニオン性界面活性剤以外で
分子内に窒素原子を有する界面活性剤との割合は前述し
た割合、すなわち分子比で20=1〜1:201好まし
くは10:1〜1:10の割合が、そのまま適用される
。In that case, the blending amount of each component is the same (although it varies depending on the type of medicinal ingredient, etc., the following range is generally the preferred blending amount range. Namely, anionic surfactant and anionic surfactant) The total blending amount of surfactants other than surfactants having nitrogen atoms in their molecules is 0.001 to 10% in cosmetics.
It is preferably 0.01 to 5% by weight, and the medicinal component is preferably 0.001 to 10% by weight, more preferably 0.01 to 5% by weight. Also,
The ratio of the anionic surfactant to the surfactant other than the anionic surfactant that has a nitrogen atom in its molecule is the ratio described above, that is, the molecular ratio is 20 = 1 to 1:201, preferably 10:1 to 1. :10 ratio is applied as is.
本発明に係る化粧料中には、上記の必須構成成分の他に
一般的に化粧料等に配合される成分を配合することがで
きる。それらの成分としては、コウホネ、オウバク抽出
物、オウゴン抽出物、アイビー抽出物、セイヨウノコギ
リソウ抽出物、センブリ抽出物、シラカバ抽出物、マロ
ニエ抽出物、ビワ抽出物、グリチルリチン酸、β−グリ
チルレチン酸、グリチルリチン酸モノアンモニウム、グ
リチルレチン酸ステアリル、ヒノキチオール、D−カン
フル、L−メントール、酸化旺釘)、カラミン、アラン
トイν、塩酸ジフェンヒドラミン等の消炎剤、ニンジン
抽出物、ゼニアオイ抽出物、ニンニク抽出物、アイリス
抽出物、ヨクイニン抽出物、ブドウ抽出物、ヘチマ抽出
物、モモ抽出物、酵母抽出物、ローヤルビリー、銅りロ
Uフィリンナトリウム、γ−オリザノール、ヒノキチオ
ール、β−カロチン、尿素、アラントイン、カラギーナ
ン、エチニルエストラジオール、L−アラニン、DL−
セリン、アデノシン三リン酸二ナトリウム、パシトテニ
ルエチルエーテル、ビオチン、イノジット、エルゴカル
シフェロール、ニコチン酸アミド等の賦活剤、クロバナ
ヒキオコシ、7−オリザノール、DL−カンフル、デキ
ストラン硫酸ナトリウム、リルイン酸DL−α−トコフ
ェロール、酢酸DL−α−トコフェロール等の血行促進
剤、レゾルシン、乳酸等の角質軟化剤、スギナ抽出物、
クワ、コウホネ、オドリコソウ抽出物、マロニエ抽出物
、ブドウリース抽出物、ヨモギ抽出物、酸化亜鉛、カラ
ミン等の収斂剤、アロエ抽出物、ユリ抽出物、クインス
シード、キサンタンガム、デキストラン硫酸ナトリウム
、コンドロイチン硫酸ナトリウム、カラギーナン、ヒア
ルロン酸ナトリウム、ウロカニン酸等の保湿剤、オリブ
油、ローヤルゼリーカキ抽出物、酵母抽出物、アスコル
ビン酸、イノジット等の栄養剤、アボカド油、サフラワ
ー油、茶実油、ホホバ油、オノニス抽出物、尿素、リノ
ール酸、コレステロール、デヒドロコレステロール、ジ
ヒドロコレステロール、ラノステロール、ステアリン酸
グリヂルレチニル等の柔軟剤、多価アル二ノ−ル、油分
、ワックス、酸、アルカリ、その他の界面活性剤、粉末
、顔料、染料、防腐間ばい剤、酸化防止剤、紫外線吸収
剤、キレート剤、水溶性高分子、モンモリロナイト、ア
ルコール、溶媒、香料等が挙げられる。In addition to the above-mentioned essential components, the cosmetics according to the present invention may contain other components that are generally included in cosmetics. These ingredients include scutellariae extract, scutellariae extract, scutellariae extract, ivy extract, yarrow extract, japonica extract, birch extract, horse chestnut extract, loquat extract, glycyrrhizinic acid, β-glycyrrhetinic acid, and glycyrrhizin. Anti-inflammatory agents such as monoammonium acid, stearyl glycyrrhetinate, hinokitiol, D-camphor, L-menthol, oxidized nails), calamine, allantoi ν, diphenhydramine hydrochloride, carrot extract, mallow extract, garlic extract, iris extract , Yokuinin extract, Grape extract, Luffa extract, Peach extract, Yeast extract, Royal Billy, Sodium Copper U fillin, γ-oryzanol, Hinokitiol, β-carotene, urea, allantoin, carrageenan, ethinyl estradiol, L-alanine, DL-
Serine, disodium adenosine triphosphate, pasitotenyl ethyl ether, biotin, inosit, ergocalciferol, activators such as nicotinamide, black snail, 7-oryzanol, DL-camphor, dextran sodium sulfate, riluic acid DL-α - Blood circulation promoters such as tocopherol and DL-α-tocopherol acetate, keratin softeners such as resorcin and lactic acid, horsetail extract,
Astringents such as mulberry, commonweed, dead manflower extract, horse chestnut extract, grape wreath extract, mugwort extract, zinc oxide, calamine, aloe extract, lily extract, quince seed, xanthan gum, sodium dextran sulfate, sodium chondroitin sulfate. , moisturizing agents such as carrageenan, sodium hyaluronate, urocanic acid, olive oil, royal jelly oyster extract, yeast extract, ascorbic acid, nutritional supplements such as Inojito, avocado oil, safflower oil, tea seed oil, jojoba oil, ononis. Extracts, urea, linoleic acid, cholesterol, dehydrocholesterol, dihydrocholesterol, lanosterol, softeners such as glydyretinyl stearate, polyhydric albinol, oil, wax, acids, alkalis, other surfactants, powders, pigments , dyes, preservatives, antioxidants, ultraviolet absorbers, chelating agents, water-soluble polymers, montmorillonite, alcohols, solvents, perfumes, etc.
[実施例]
つぎに実施例を挙げて本発明を具体的に説明するが、本
発明はこれら実施例にのみ限定されるものではない。配
合量は重量%である。[Examples] Next, the present invention will be specifically explained with reference to Examples, but the present invention is not limited only to these Examples. The blending amount is in weight%.
実施例1 クリーム
(1) アスコルビン酸2−硫酸
(2) ブ1]ピレングリコール
(3) グリセリン
(4) 流動パラフィン
(5) アジピン酸シイツブ[1ピル(6)
ドデシル硫酸ナトリウム
(7) ドデシルジメチル
アミンオキ→ノ゛イド
(8) グリセリンモノ
脂肪酸エステル
1.0
8.0
5.0
1.0
3.0
0、O8
0,16
1,5
(9) 防腐剤 適量(10)
粘土鉱物(ベントナイト)6.0(11) 精製水
残余比較例1 クリーム
(1) アスコルビン酸2−硫酸
(2) プl」ピレングリコール
(3) グリセリン
(4) 流動パラフィン
(5) アジピン酸ジイソプロピル((S)
グリセリンモノ
脂肪酸エステル
(7) 防腐剤
(8) 粘土鉱物(ベントナイト)
(9) 精製水
1.0
8.0
5.0
1.0
3.0
1.5
適量
6.0
残余
実施例1及び比較例1で調整したクリームについて、美
白効果を比較した。試験方法及び評価方法を以下に示す
。Example 1 Cream (1) Ascorbic acid 2-sulfuric acid (2) Pyrene glycol (3) Glycerin (4) Liquid paraffin (5) Adipic acid 1 pill (6)
Sodium dodecyl sulfate (7) Dodecyldimethylamine oxide→noid (8) Glycerin monofatty acid ester 1.0 8.0 5.0 1.0 3.0 0, O8 0.16 1.5 (9) Preservative Appropriate amount (10)
Clay mineral (bentonite) 6.0 (11) Purified water Residue comparative example 1 Cream (1) Ascorbic acid 2-sulfuric acid (2) Pyrene glycol (3) Glycerin (4) Liquid paraffin (5) Diisopropyl adipate ( (S)
Glycerin monofatty acid ester (7) Preservative (8) Clay mineral (bentonite) (9) Purified water 1.0 8.0 5.0 1.0 3.0 1.5 Appropriate amount 6.0 Remaining Example 1 and comparison The whitening effect of the cream prepared in Example 1 was compared. The test method and evaluation method are shown below.
すなわち、肝斑患者女子各20名の顔部に、実施例1及
び比較例1で調整したクリームを4週間連用し、その前
後において判定した。That is, the creams prepared in Example 1 and Comparative Example 1 were continuously applied to the faces of 20 female melasma patients for 4 weeks, and evaluations were made before and after that.
判定基準は、
「肝斑の著明な改善効果」 (スコア2)「明らかな改
善効果」 (スコア1)
「黴弱な改善効果」 (スコア0.5)「変化なし」
(スコアO)
として各基剤別に平均スコアを求めた。Judgment criteria are: "Remarkable improvement effect on melasma" (Score 2) "Obvious improvement effect" (Score 1) "Slight improvement effect on mold" (Score 0.5) "No change"
(Score O) An average score was determined for each base.
表−1
表−1より明らかな様に実施例1のクリームか美白作用
に優れていることがわかる。Table 1 As is clear from Table 1, it can be seen that the cream of Example 1 has excellent whitening effect.
実施例2 クリーム
(1) コウジ酸
(2) デヒドロコレステ1]−ル2.0
0.5
茶実油
グリセリンモノ
脂肪酸エステル
ドデシル硫酸ナトリウム
ドデシルリン酸ナトリウム
ソジウムラウリル
イソチオネート
ドデシルジメチル
アミンオキサイド
ラウリン酸ジェタ
ノールアミド
流動パラフィン
セタノール
防腐剤
粘土鉱物(ベントナイト)
香料
イオン交換水
0.2
1.4
0.5
0.6
0.2
1.14
0.2
4.0
1.0
適量
5.0
適量
残余
比較例3 クリーム
(1) コウジ酸
2.0
デヒドロコレステロール
茶実油
グリセリンモノ
脂肪酸エステル
流動パラフィン
セタノール
防腐剤
粘土鉱物(ベントナイト)
香わ1
イオン交換水
0.5
0.2
1.4
4.0
1.0
適量
5.0
適量
残余
実施例2、比較例2の美白効果も同様な方法で試験した
。結果を表−2に示した。Example 2 Cream (1) Kojic acid (2) Dehydrocholesterol 2.0 0.5 Tea seed oil Glycerin Monofatty acid ester Sodium dodecyl sulfate Sodium dodecyl phosphate Sodium lauryl isothionate Dodecyl dimethylamine oxide lauric acid Jetanolamide Liquid paraffin Setanol Preservative Clay mineral (bentonite) Fragrance Ion exchange water 0.2 1.4 0.5 0.6 0.2 1.14 0.2 4.0 1.0 Appropriate amount 5.0 Appropriate amount remaining Comparative Example 3 Cream (1) Kojic acid 2.0 Dehydrocholesterol Teaseed oil Glycerin Monofatty acid ester Liquid paraffin Cethanol Preservative Clay mineral (bentonite) Fragrance 1 Ion exchange water 0.5 0.2 1.4 4.0 1 .0 Appropriate amount 5.0 Appropriate amount Remaining Example 2 and Comparative Example 2 were tested for whitening effect in the same manner. The results are shown in Table-2.
表−2
美白作用に優れていることかわかる。また皮膚柔軟性に
おいても優れた効果を示した。Table 2: It can be seen that it has excellent whitening effect. It also showed excellent effects on skin flexibility.
実施例3 ヘアトニック
1 ピロクトンオラミン 1.02 酢酸
DL−α−トコフェロール 0.33 ユリ抽出物
0.054) 塩酸ピーリドキシン
0.075 ヒノキチール
0.036 ドデシル硫酸すトリウム
0.27 ドデシルジメチル
アミンオキサイド 0.7
(8) ポリオキシエチレン(40モル付加)硬化ヒ
マシ油誘導体 0.5
(9) エチルアルコール 50.0(
10)桜(りi剤 適量(1
1)香料 適量(12)精製
水 残余表−2より明らかな様
に実施例2のクリームが比較例3 ヘアトニック
(1ピロクトンオラミン 1.0(2酢酸
DL−α−トコフェロール 0.3(3ユリ抽出物
0,05(4塩酸ビリドギシン
0.07(5ヒノキチール
0.03(6ボリオギシエヂレン(40モル付
加)硬化ヒマシ油誘導体 0.5
(7) エチルアルコール 50.0(
8) 緩(÷i剤 適量(
9) 香料 適量(10)
精製水 残余を使用し、試験期
間終了時の最?(の洗髪後3日間に累積しLlふけの重
量とを比較した。累積したふけの採取は濾布つき吸引装
置を用いて頭部を吸弓することにより行なった。Example 3 Hair Tonic 1 Piroctone Olamine 1.02 DL-α-Tocopherol Acetate 0.33 Lily Extract
0.054) Piridoxine hydrochloride 0.075 Hinokitiru
0.036 Sothorium dodecyl sulfate
0.27 Dodecyldimethylamine oxide 0.7 (8) Polyoxyethylene (40 mol addition) hydrogenated castor oil derivative 0.5 (9) Ethyl alcohol 50.0 (
10) Sakura (li agent appropriate amount (1)
1) Fragrance Appropriate amount (12) Purified water As is clear from Residue Table 2, the cream of Example 2 has the following properties: 3 Lily extract
0,05 (pyridogycine tetrahydrochloride
0.07 (5 Hinoki Chiru
0.03 (6-boriogysyethylene (40 mol addition)) Hydrogenated castor oil derivative 0.5 (7) Ethyl alcohol 50.0 (
8) Gentle (÷i agent appropriate amount)
9) Appropriate amount of fragrance (10)
Purified water Use the remaining water and refill it at the end of the test period. The weight of Ll dandruff accumulated over 3 days after hair washing was compared with that of dandruff. Accumulated dandruff was collected by sucking the head using a suction device equipped with a filter cloth.
ヘアトニック使用に、よるふけの減少は以下の式で算出
した。The reduction in dandruff caused by the use of hair tonic was calculated using the following formula.
実施例3、比較例3のふけ抑制試験を行なった。A dandruff suppression test was conducted for Example 3 and Comparative Example 3.
試験方法及び評価方法を以下に示す。The test method and evaluation method are shown below.
対象名゛として22〜36歳で、ふけの比較的多い男性
を12名選び、各試料につき、6名ずつ合記12名につ
いてテストを行なった。試験開始前に普通のシャンプー
で洗髪し、洗髪後3日間に累積しふけを採取し、採取し
たふけの重量と、1力月間、上記実施例3及び比較例3
て調製したヘア1−二ツク(以下余白)
表−3
表−3より明らかな様に実施例3のヘアトニックがふけ
抑制効果に優れていることかわかる。Twelve men between the ages of 22 and 36 with relatively heavy dandruff were selected as subjects, and each sample was tested on a total of 12 men, six men each. Before the start of the test, wash your hair with a normal shampoo, collect the accumulated dandruff for 3 days after washing, and compare the weight of the collected dandruff with the weight of the collected dandruff and the weight of each month, Example 3 and Comparative Example 3 above.
Table 3 As is clear from Table 3, the hair tonic of Example 3 has an excellent dandruff suppressing effect.
つ
塩酸ピリドキシン
サリチル酸
ビワ抽出物
I−−メントール
セフノール
ワセリンP
スクワラン
ジメヂルボリシロキサン
アシルメチルタウリンNa
ラウリルベタイン
グリセリンモノステアレート
グリセリン
ジプロピレングリコール
カルボキシビニルポリマー
OH
防腐剤
古事;↓
イオン交換水
0.05
0.1
0.02
0.2
1.0
2.0
4.0
2.0
0.6
0.8
2.0
5.0
4.0
0.3
0.1
適量
適量
残余
実施例4
乳液
比較例4 乳τイl
塩酸ピリドキシン
サリチル酸
ビワ抽出物
L−メントール
セタノール
ワセリンP
スクワラン
ジメチルボリシロキザン
グリセリンモノステアレート
グリセリン
ジプロピレングリコール
カルボキシビニルポリマー
OH
防腐剤
占t’t
イオン交換水
0.05
0.1
0.02
0.2
1.0
2.0
4.0
2.0
2.0
5.0
4.0
0.3
0.1
ia量
iI¥1景
残余
すなわち、にきびに悩む健康な女性20名の顔部に、実
施例4及び比較例4で調整した乳液を4週間連用し、そ
の前後において判定した。Pyridoxine hydrochloride Salicylic acid Loquat extract I--Menthol Cefnol Petrolatum P Squalane Dimethylpolysiloxane Acylmethyl taurine Na Lauryl betaine Glycerin monostearate Glycerin Dipropylene glycol Carboxy vinyl polymer OH Preservative; ↓ Ion exchange water 0.05 0 .1 0.02 0.2 1.0 2.0 4.0 2.0 0.6 0.8 2.0 5.0 4.0 0.3 0.1 Appropriate amount Appropriate amount remaining Example 4 Emulsion comparative example 4 Milk τil Pyridoxine hydrochloride salicylic acid Loquat extract L-menthol cetanol Vaseline P Squalane dimethyl borisiloxane glycerin monostearate Glycerin dipropylene glycol carboxyvinyl polymer OH Preservatives t't Ion exchange water 0.05 0.1 0 .02 0.2 1.0 2.0 4.0 2.0 2.0 5.0 4.0 0.3 0.1 ia amount iI ¥1 image residual, that is, 20 healthy women suffering from acne. The emulsions prepared in Example 4 and Comparative Example 4 were applied to the face for 4 weeks, and evaluations were made before and after.
判定基準は、
「アクネの著明な改善効果」 (スコア2)「明らかな
改善効果」 (スコア1)
「黴弱な改善効果」 (スコア0.5)「変化なし」
(スコアO)
として各基剤側に平均スコアを求めた。結果を表−4に
示した。Judgment criteria are: ``Remarkable improvement effect on acne'' (score 2) ``Obvious improvement effect'' (score 1) ``Slight improvement effect on mold'' (score 0.5) ``No change''
(Score O) An average score was determined for each base side. The results are shown in Table-4.
表−4
実施例4及び比較例4で調整した乳液について、アクネ
改善効果を比較した。試験方法及び評価方法については
、以下に示す。Table 4 The acne-improving effects of the emulsions prepared in Example 4 and Comparative Example 4 were compared. The test method and evaluation method are shown below.
表−4より明らかな様に実施例4の乳液がアクネ改善効
果に優れている事がわかる。As is clear from Table 4, it can be seen that the emulsion of Example 4 has an excellent acne-improving effect.
実施例5
ヘアリキッド
トリクロロカルバニリド
酢酸DL−α−トコフコニロール
ポリオキシプロピレン
(40モル付加)ブチルエーテル
エチルアルコール
アシルグルタミン酸モノNa
オレイルジメチル
アミンオキサイド
香料
イオン交換水
0.3
(5)ラウリルジメチル
0.1
15.0
50.0
0.4
1.2
適量
残余
アミンオキサイド
6)グリセリン
?)1.3−ブチレングリコール
8)エチルアルコール
9)防腐剤
10)緩衝剤
11)イオン交換水
0.6
2.0
1.0
10.0
適量
適量
残余
本実施例6の化粧水は、すぐれた美白作用を示し、かつ
皮膚賦活作用も示した。Example 5 Hair liquid trichlorocarbanilide acetic acid DL-α-tocofucconylol polyoxypropylene (40 mol addition) butyl ether ethyl alcohol acyl glutamate monosodium oleyl dimethylamine oxide fragrance ion-exchanged water 0.3 (5) lauryl dimethyl 0. 1 15.0 50.0 0.4 1.2 Appropriate amount of residual amine oxide 6) Glycerin? ) 1.3-Butylene glycol 8) Ethyl alcohol 9) Preservative 10) Buffer 11) Ion exchange water 0.6 2.0 1.0 10.0 Appropriate amount Appropriate amount Residual The lotion of Example 6 has excellent It showed a whitening effect and also showed a skin revitalizing effect.
本実施例5のへアリギッドは、すぐれたふけ抑制効果を
示した。The Hearigid of Example 5 showed excellent dandruff suppressing effects.
実施例6 化粧水
(1)アスコルビン酸2−硫酸
(2プラセンタ抽出物
(3)バントテニルエチルエーテル
(4)ラウロイルグルタメート
モノナトリウム
0.3
0.2
0.2
0.5
[発明の効果]
本発明に係る化粧料は、薬効成分の持つ効果を充分発揮
させ、かつ安全性、使用感触も良好な化オル本゛Iであ
る。Example 6 Lotion (1) Ascorbic acid 2-sulfuric acid (2) Placenta extract (3) Bantothenyl ethyl ether (4) Monosodium lauroyl glutamate 0.3 0.2 0.2 0.5 [Effects of the invention] This invention The cosmetic according to the invention is a cosmetic that fully exhibits the effects of medicinal ingredients and is safe and feels good when used.
特許出願人 株式会社 資生堂Patent applicant: Shiseido Co., Ltd.
Claims (1)
ニオン性界面活性剤以外で分子内に窒素原子を有する界
面活性剤の一種又は二種以上と、美白剤、フケ防止剤及
び抗脂漏剤からなる群から選ばれる一種又は二種以上と
を含有することを特徴とする化粧料。(1) One or more anionic surfactants, one or two or more surfactants other than anionic surfactants that have a nitrogen atom in the molecule, and a whitening agent, anti-dandruff agent, and anti-grease agent. A cosmetic containing one or more selected from the group consisting of leakage agents.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63199787A JP2602070B2 (en) | 1988-08-12 | 1988-08-12 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63199787A JP2602070B2 (en) | 1988-08-12 | 1988-08-12 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0249714A true JPH0249714A (en) | 1990-02-20 |
| JP2602070B2 JP2602070B2 (en) | 1997-04-23 |
Family
ID=16413604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63199787A Expired - Fee Related JP2602070B2 (en) | 1988-08-12 | 1988-08-12 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2602070B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0812529A (en) * | 1994-06-23 | 1996-01-16 | Riken Health Kk | Transparent hair-raising agent |
| FR2738743A1 (en) * | 1995-09-19 | 1997-03-21 | Oreal | USE OF ASCORBIC ACID AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF SEBORRHEA IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS595107A (en) * | 1982-07-01 | 1984-01-12 | Shiseido Co Ltd | Keratolytic |
| JPS6178711A (en) * | 1984-09-21 | 1986-04-22 | ロレアル | Cosmetic composition for application to hair |
| JPS61210036A (en) * | 1985-03-15 | 1986-09-18 | Shiseido Co Ltd | Sulfur-compounded external drug for skin |
| JPS61257913A (en) * | 1985-05-09 | 1986-11-15 | Kao Corp | Dentifrice composition |
| JPS62246506A (en) * | 1986-12-02 | 1987-10-27 | Ichimaru Pharcos Co Ltd | Skin cosmetic containing extract of hydrolyzed 'yokuinin' |
| JPS6479103A (en) * | 1987-06-09 | 1989-03-24 | Lion Corp | External preparation |
| JPH0236117A (en) * | 1988-07-27 | 1990-02-06 | Kansai Paint Co Ltd | Skin-cleaning cosmetic |
| JPH0242016A (en) * | 1988-08-01 | 1990-02-13 | Kansai Paint Co Ltd | Facial cleansing agent |
-
1988
- 1988-08-12 JP JP63199787A patent/JP2602070B2/en not_active Expired - Fee Related
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS595107A (en) * | 1982-07-01 | 1984-01-12 | Shiseido Co Ltd | Keratolytic |
| JPS6178711A (en) * | 1984-09-21 | 1986-04-22 | ロレアル | Cosmetic composition for application to hair |
| JPS61210036A (en) * | 1985-03-15 | 1986-09-18 | Shiseido Co Ltd | Sulfur-compounded external drug for skin |
| JPS61257913A (en) * | 1985-05-09 | 1986-11-15 | Kao Corp | Dentifrice composition |
| JPS62246506A (en) * | 1986-12-02 | 1987-10-27 | Ichimaru Pharcos Co Ltd | Skin cosmetic containing extract of hydrolyzed 'yokuinin' |
| JPS6479103A (en) * | 1987-06-09 | 1989-03-24 | Lion Corp | External preparation |
| JPH0236117A (en) * | 1988-07-27 | 1990-02-06 | Kansai Paint Co Ltd | Skin-cleaning cosmetic |
| JPH0242016A (en) * | 1988-08-01 | 1990-02-13 | Kansai Paint Co Ltd | Facial cleansing agent |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0812529A (en) * | 1994-06-23 | 1996-01-16 | Riken Health Kk | Transparent hair-raising agent |
| FR2738743A1 (en) * | 1995-09-19 | 1997-03-21 | Oreal | USE OF ASCORBIC ACID AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF SEBORRHEA IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION |
| JPH09110628A (en) * | 1995-09-19 | 1997-04-28 | L'oreal Sa | Cosmetic and / or dermatological composition containing ascorbic acid as active agent for treating seborrhea |
| EP0771557A1 (en) * | 1995-09-19 | 1997-05-07 | L'oreal | Use of ascorbic acid as the actif for the treatment of seborrhea in a cosmetic and/or dermatalogical composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2602070B2 (en) | 1997-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU670448B2 (en) | Cosmetic composition in the form of a water/oil/water triple emulsion with gelled external phase | |
| JPH11501954A (en) | Use of octoxyglycerin as an active agent for treating seborrhea and / or acne in cosmetic and / or dermatological compositions | |
| EP0294808A1 (en) | Agent for external application and use thereof | |
| JPH07291824A (en) | Cosmetic and / or dermatological composition containing glyceryl tri (α-hydroxyacylate) | |
| CN111491610A (en) | Foaming aqueous composition comprising penicillic acid, alkyl polyglycoside and polysaccharide | |
| WO2020263188A1 (en) | Triterpenoids that decrease lipid production in sebocytes | |
| JP4070065B2 (en) | Skin preparation for preventing and improving skin roughness | |
| JP2002003373A (en) | Skin care preparation | |
| ES2261173T3 (en) | USE OF POLYAMINOACID DERIVATIVES TO TREAT SEBORREA AND CUTANEOUS ALTERATIONS. | |
| WO2020263189A1 (en) | Phenols that decrease lipid production in sebocytes | |
| JP2928203B2 (en) | Skin cleansing composition containing succinic anhydride derivative | |
| JPH05262635A (en) | Dermatic external preparation | |
| JPH11139951A (en) | Cosmetics | |
| JP2004051521A (en) | Cosmetics containing dry cosmetic ingredients in non-woven fabric | |
| JP2602069B2 (en) | Cosmetics | |
| JPH0995432A (en) | Preparation for external use for skin | |
| JPH0249714A (en) | Cosmetic | |
| WO2020263190A1 (en) | Xanthones that decrease lipid production in sebocytes | |
| JP2000212057A (en) | Cosmetic composition | |
| JPH0249712A (en) | Cosmetic | |
| JP2000007548A (en) | Skin lotion | |
| JPH07138125A (en) | Topical skin | |
| JPH07304626A (en) | Cosmetic having improved moisture retention | |
| JPH08157337A (en) | Hair cosmetic | |
| JPH10279427A (en) | Moisture-retaining cosmetic material composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |